Cargando…
Outcome Reporting Variability in Trials of Chinese Medicine for Hyperlipidemia: A Systematic Review for Developing a Core Outcome Set
INTRODUCTION: Hyperlipidemia is an underlying process behind cardiovascular disease. Chinese medicine (CM) may be effective in treating hyperlipidemia, but there is a lack of studies with high methodological quality. A major reason for this is heterogeneity in outcome reporting. Therefore, this stud...
Autores principales: | Li, Geng, Han, Ruxue, Cao, Wencong, Wen, Zehuai, Chen, Xiankun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211496/ https://www.ncbi.nlm.nih.gov/pubmed/34211576 http://dx.doi.org/10.1155/2021/8822215 |
Ejemplares similares
-
Developing a Core Outcome Set for Clinical Trials of Chinese Medicine for Hyperlipidemia
por: Li, Geng, et al.
Publicado: (2022) -
A core outcome set for clinical trials of Chinese medicine for hyperlipidemia: a study protocol for a systematic review and a Delphi survey
por: Li, Geng, et al.
Publicado: (2019) -
Development of CORE-CM core outcome domain sets for trials of Chinese medicine for lumbar spinal stenosis
por: Sun, Ya-Nan, et al.
Publicado: (2023) -
Protocol of the Development of a Core Outcome Set for Ischemic Stroke in Clinical Trials of Chinese Medicine
por: Xie, Qianwen, et al.
Publicado: (2020) -
Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine
por: Qiu, Ruijin, et al.
Publicado: (2020)